A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors - Adra, Nabil; Vaughn, David J.; Einhorn, Lawrence H.; Hanna, Nasser H.; Funt, Samuel A.; Rosales, Matt; Arozullah, Ahsan; Feldman, Darren R. (Investigational new drugs, 2022)
Keywords: Adult; Antibodies; Antibodies, Monoclonal - adverse effects; Anticancer properties; Antineoplastic Agents - adverse effects; Antitumor activity; Biomarkers; Chemotherapy; Effectiveness; Embryos; Epithelium; Histology; Humans; Immunoglobulin G; Immunohistochemistry; Male; Males; Medicine; Medicine & Public Health; Membranes; Middle Aged; Neoplasm Recurrence, Local - drug therapy; Neoplasms, Germ Cell and Embryonal - drug therapy; Oncology; Patients; Pharmacology/Toxicology; Safety; Seminoma; Staining; Testicular cancer; Testicular Neoplasms - drug therapy; Therapeutic targets; Toxicity; Tumors; Young Adult; Germ cell tumor; Testicular cancer; ASP1650